NCT06865768View on ClinicalTrials.gov

An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique

PHASE2RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

April 18, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Prostate Carcinoma
Interventions
DRUG

Flotufolastat F-18 Gallium

Given IV

PROCEDURE

Magnetic Resonance Imaging

Undergo TRUS-MR fusion biopsy

PROCEDURE

Multiparametric Magnetic Resonance Imaging

Undergo mpMRI

PROCEDURE

Positron Emission Tomography

Undergo PET

PROCEDURE

Transrectal Ultrasonography Guided Biopsy

Undergo TRUS-MR fusion biopsy

Trial Locations (1)

30322

RECRUITING

Emory University Hospital, Atlanta

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

Emory University

OTHER